I see that shares of $HIMS have fallen more than 60% from their all-time highs (ATH), which is no small amount. I personally don't follow this company closely right now, but I'd be interested to know the main reasons for this decline.
Does anyone have any idea why $HIMS shares have dropped so significantly? Do you see it more as an opportunity or as a trap?
I own some and I'm considering buying more. They have excellent results, the market is large, and they've even started international expansion in telehealth. The market may be wondering whether that rapid growth is sustainable. And in the US everyone is probably nervous about Trump's interference in this segment. They'll likely be sparring again with the big US market player, company $NVO, over the weight-loss drug they devised themselves, with Wegovy as their benchmark. It probably isn't for someone who doesn't like big swings, but their business model is hard to deny.
I'm no longer very interested in these companies and I keep my distance. For these firms it's just a question of whether they manage to develop some great drug or not.
